CAS 1369530-77-7

Formula: C10H9BrFNO3

InChI: InChI=1S/C10H9BrFNO3/c11-8-2-1-6(3-9(8)12)13-4-7(5-14)16-10(13)15/h1-3,7,14H,4-5H2/t7-/m0/s1

InChI key: UGBKYDASQNOIHP-ZETCQYMHSA-N

SMILES: C1[C@H](OC(=O)N1C2=CC(=C(C=C2)Br)F)CO

(S)-3-(4-Bromo-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one

CAS: 1369530-77-7

(S)-3-(4-Bromo-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one

Formula: C₁₀H₉BrFNO₃

Purity: 95%

Molecular weight: 290.09

Ref: 54-PC1002312

(S)-3-(4-Bromo-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one

CAS: 1369530-77-7

Formula: C₁₀H₉BrFNO₃

Purity: 95%

Color and Shape: Solid

Molecular weight: 290.0858

Ref: IN-DA0012LG

Tedizolid Impurity 38

CAS: 1369530-77-7

Formula: C₁₀H₉BrFNO₃

Color and Shape: White To Off-White Solid

Molecular weight: 290.09

Ref: 4Z-T-163041

(S)-3-(4-Bromo-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one

CAS: 1369530-77-7

(S)-3-(4-Bromo-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one

Formula: C₁₀H₉BrFNO₃

Purity: 95%

Molecular weight: 290.09

Ref: IN-DG629212

(5S)-3-(4-Bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one

Controlled Product

CAS: 1369530-77-7

Applications (5S)-3-(4-Bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one is obtained from (4-Bromo-3-fluorophenyl)carbamic Acid Benzyl Ester (B683310) which is an intermediate in the synthesis of Tedizolid (T013750), an known oral and intravenous antibiotic.
References PCT Int. Appl. (2008), WO 2008126034 A2 20081023.

Formula: C₁₀H₉BrFNO₃

Color and Shape: Neat

Molecular weight: 290.086

Ref: TR-B689155

(5S)-3-(4-Bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one

CAS: 1369530-77-7

Tedizolid phosphate is a medicine that belongs to the class of medicines known as pinacol esters. It is used in the treatment of industrial condition and Tedizolid is used for the treatment of serious infections caused by bacteria, such as Lyme disease and Rocky Mountain spotted fever. Pinacol ester undergoes hydrolysis by esterases or glucuronidases, oxidation by cytochrome P450 enzymes, reduction by glutathione reductase, or conjugation with glucuronic acid. Tedizolid phosphate has been shown to be effective against methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium perfringens, although is not active against acid-fast bacteria such as Mycobacterium tuberculosis or Mycobacterium avium complex.

Formula: C₁₀H₉BrFNO₃

Purity: Min. 95%

Molecular weight: 290.09 g/mol

Ref: 3D-UEC53077